Andrew Cooper
Stock Analyst at Raymond James
(3.34)
# 1,040
Out of 5,072 analysts
151
Total ratings
47.01%
Success rate
2.55%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintains: Outperform | $35 → $45 | $36.27 | +24.07% | 3 | Nov 25, 2025 | |
| ITGR Integer Holdings | Reiterates: Outperform | $143 → $95 | $72.04 | +31.87% | 4 | Oct 24, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | n/a | $74.80 | - | 13 | Oct 22, 2025 | |
| AVTR Avantor | Maintains: Outperform | $14 → $16 | $11.74 | +36.29% | 16 | Oct 16, 2025 | |
| HAE Haemonetics | Downgrades: Outperform | $105 → $78 | $80.75 | -3.41% | 10 | Aug 11, 2025 | |
| GH Guardant Health | Maintains: Outperform | $59 → $61 | $107.79 | -43.41% | 4 | Jul 31, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $120 → $115 | $104.66 | +9.88% | 9 | Jul 29, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $525 → $535 | $593.25 | -9.82% | 7 | Jul 24, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $19 → $10 | $7.60 | +31.58% | 5 | May 7, 2025 | |
| FLGT Fulgent Genetics | Reiterates: Outperform | $24 → $25 | $30.15 | -17.08% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $224.67 | - | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $228.46 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $101.45 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $17.81 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $237.12 | -64.15% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $27.50 | +176.36% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $5.60 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.13 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $47.71 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.38 | - | 5 | Sep 22, 2021 |
Azenta
Nov 25, 2025
Maintains: Outperform
Price Target: $35 → $45
Current: $36.27
Upside: +24.07%
Integer Holdings
Oct 24, 2025
Reiterates: Outperform
Price Target: $143 → $95
Current: $72.04
Upside: +31.87%
Hologic
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $74.80
Upside: -
Avantor
Oct 16, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $11.74
Upside: +36.29%
Haemonetics
Aug 11, 2025
Downgrades: Outperform
Price Target: $105 → $78
Current: $80.75
Upside: -3.41%
Guardant Health
Jul 31, 2025
Maintains: Outperform
Price Target: $59 → $61
Current: $107.79
Upside: -43.41%
Revvity
Jul 29, 2025
Reiterates: Outperform
Price Target: $120 → $115
Current: $104.66
Upside: +9.88%
Thermo Fisher Scientific
Jul 24, 2025
Reiterates: Outperform
Price Target: $525 → $535
Current: $593.25
Upside: -9.82%
Myriad Genetics
May 7, 2025
Reiterates: Outperform
Price Target: $19 → $10
Current: $7.60
Upside: +31.58%
Fulgent Genetics
May 5, 2025
Reiterates: Outperform
Price Target: $24 → $25
Current: $30.15
Upside: -17.08%
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $224.67
Upside: -
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $228.46
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $101.45
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $17.81
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $237.12
Upside: -64.15%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $27.50
Upside: +176.36%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $5.60
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $12.13
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $47.71
Upside: -
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $2.38
Upside: -